Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
Vedanta, Hindalco, and other metal stocks slide up to 6% on growth concerns amid trade war
The shares of National Aluminium Company (NALCO) dipped the highest, falling by 6% to an intraday low of Rs 162.40, followed by Vedanta shares, which
April 4, 2025